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Abstract
 Aims We assessed the changes in cardiac morphology between elite endurance-trained runners (n = 42)
and elite sprinters (n = 34) over a 5-year period. In addition, we studied the relationship between heart
size and maximum oxygen consumption (VO2 max). Methods At the beginning of 5 consecutive
seasons, all athletes underwent an incremental running test to determine VO2 max and a color-coded
pulsed Doppler examination to determine baseline echocardiographic variables. We hypothesized that
cardiac morphology had reached its upper limit in elite athletes, and showed only minor changes during
5 years of regular training. Results Although all echocardiographic variables remained stable in nearly
all sprinters studied, in the endurance runners (who presented higher cardiac cavity dimensions
compared with sprinters), variations in heart morphology became evident from the third season, and
were within established physiological limits. Conclusion Only 6 (17%) endurance runners and 3 (9%)
sprinters showed a left ventricular internal diameter of > 60 mm (the threshold pathological value) at
end diastole at some point during the observational period. Moreover, no statistically significant
association was detected between changes in VO2 max and changes in heart size. After 5 years of
intense training, the changes of the echocardiographic variables examined remained different between
endurance runners and sprinters.
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Abstract: Aims We assessed the changes in 
cardiac morphology between elite endurance-trained runners (n = 42) and elite sprinters (n = 34) over a 
5-year period. In addition, we studied the relationship between heart size and maximum oxygen 
consumption (VO2 max). Methods At the beginning of 5 consecutive seasons, all athletes underwent 
an incremental running test to determine VO2 max and a color-coded pulsed Doppler examination to 
determine baseline echocardiographic variables. We hypothesized that cardiac morphology had 
reached its upper limit in elite athletes, and showed only minor changes during 5 years of regular 
training. Results Although all echocardiographic variables remained stable in nearly all sprinters 
studied, in the endurance runners (who presented higher cardiac cavity dimensions compared with 
sprinters), variations in heart morphology became evident from the third season, and were within 
established physiological limits. Conclusion Only 6 (17%) endurance runners and 3 (9%) sprinters 
showed a left ventricular internal diameter of > 60 mm (the threshold pathological value) at end 
diastole at some point during the observational period. Moreover, no statistically significant association 
was detected between changes in VO2 max and changes in heart size. After 5 years of intense training, 
the changes of the echocardiographic variables examined remained different between endurance 
runners and sprinters. 
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Introduction 
Noninvasive cardiology techniques (eg, echocardiography, Doppler echocardiography, and nuclear 
magnetic resonance) allow accurate assessment of cardiac adaptations to training. The enlargement of 
the heart chambers, increase of the end-diastolic interventricular septal thickness (IVSTd), end-
diastolic posterior wall thickness (PWTd), and maintenance of the IVSTd/PWTd ratio document 
physiological cardiac hypertrophy as a consequence of training.1-5  
One of the distinct features of physiological adaptations versus pathological adaptations in heart 
morphology is the tendency to return toward baseline values with cessation of or decrease in training, 
although the process of adaptation to training is more obvious than adaptation to detraining.6 The 
increase in heart dimensions (expressed as the increase in the size of the left ventricular internal 
diameter at end diastole [LVIDd]) and hypertrophy (expressed as the increase in the PWTd) are 
adaptations to high-load training.7-9 The pathological threshold of these adaptations has been 
established as 60 mm for LVIDd.3,5,10,11  
The cardiac adaptations to different types of training are still not defined clearly.6,12-14 We performed a 
longitudinal echocardiographic study of nationally and internationally ranked runners over 5 seasons to 
determine intense training-induced heart adaptations in elite endurance runners and elite sprinters. 
Additional aims were to: 1) evaluate whether heart dimensions of elite runners increase above 
physiological levels; 2) identify any differences in cardiac adaptation between endurance-trained 
runners and sprint-trained runners; and 3) detect any relationship between echocardiographic variables 
measured at rest and peak performance (ie, at the time of reaching maximum oxygen consumption 
[VO2 max]), which was measured via an incremental treadmill running test. 
Materials and Methods 
Participants 
This study was approved by the local ethics committee. All participants were informed of the nature of 
the tests, and all provided written informed consent to participate in the study. From 1995 to 2005, a 
cohort of 76 men who had been training for ≥ 10 years, including competing for ≥ 5 years at national 
and international levels, completed 1 test per year during 5 consecutive years. The athletes were 
grouped into sprint-trained runners (n = 34; distance ≤ 400 m; age, 23.2 ± 2.4 years; height, 178.1 ± 
10.0 cm; body mass, 75.0 ± 6.3 kg; absolute VO2 max, 4.7 ± 0.5 L·min−1; VO2 max/kg, 62.6 ± 3.5 
mL·min−1·kg−1) and endurance-trained runners (n = 42; distance, > 400 m; age, 24.5 ± 3.2 years; 
height, 181.1 ± 8.2 cm; body mass, 73.2 ± 4.0 kg; VO2 max, 4.9 ± 0.5 L·min−1; absolute VO2 max/kg, 
66.9 ± 3.5 mL·min−1·kg−1). 
Study Protocol 
As part of their yearly medical preparticipation screening examination, the athletes underwent an 
echocardiographic examination and an incremental treadmill exercise test to exhaustion at the 
beginning of each season over the 5 consecutive seasons. 
Echocardiography 
The echocardiographic examinations were performed by 2 experienced physicians using a Toshiba 
SSH-140 ultrasonograph (Toshiba Medical Systems SA, Madrid, Spain). This equipment allows for 1- 
and 2-dimensional images (M-mode and 2-dimensional, respectively), and provides continuous and 
color-coded pulsed Doppler examinations. The 25-MHz electronic transducer used employed phased 
array technology, with an axial resolution of 0.6 mm. The equipment uses its own software to measure 
and calculate all conventional echocardiographic variables. 
Both M-mode and 2-dimensional images were at a 45° angle, with the athletes in the left semilateral 
decubitus position; conventional planes were visualized by placing the transducer in the corresponding 
positions.15 The IVSTd, PWTd, and the diameter of the ventricles in the 2 phases of the cardiac cycle 
were determined via the long parasternal projection axis in M-mode, guided by real time 2-dimensional 
images and the electrocardiographic (ECG) signal obtained from a CM5 lead. Diastolic measurements 
were taken at the moment coinciding with the start of the QRS complex; systolic measurements were 
taken at the moment of greatest posterior displacement of the septum. When measuring thickness, 
special care was taken not to include echocardiograms from trabeculated areas (ie, the cordae tendinae 
of the left ventricle), or the subvalve apparatus and moderator band of the right ventricle. All 
measurements were made according to the norms of the American Society of Echocardiography. 
End-diastolic volume (EDV) and end-systolic volume (ESV) were calculated using the Teichholz 
equation.16 Subsequently, stroke volume was calculated as the difference between EDV and ESV. 
Body surface area was calculated with the DuBois equation, and left ventricular mass was calculated 
using the Deveraux equation.9  
To determine the reproducibility of echocardiographic measurements, 35 subjects were randomly 
selected and evaluated by both operators, and interobserver variability was determined using the 
following parameters: left ventricular internal diameter at end systole (LVIDs), LVIDd, IVSTd, and 
PWTd. In addition, the coefficient of variation between the results of these observers and those of a 
highly experienced expert was calculated to ensure that the 2 observers’ measurements were correct. 
Incremental Test 
All athletes (42 endurance runners and 34 sprinters) who enrolled in the study underwent an 
incremental treadmill running test (H/P/COSMOS 3P 4.0®, H/P/Cosmos Sports & Medical, Nussdorf-
Traunstein, Germany) at a 1% slope. After a 3-minute warm-up period at a speed of 6 km·h−1, the 
speed was increased 1 km·h−1 every minute until exhaustion. During this test, gas analysis was 
performed using the Jaeger Oxycon Pro gas analyzer (Erich Jaeger, Viasys Healthcare, Germany).17,18 
Maximum oxygen consumption was determined as the mean of the 2 highest values recorded at the 
maximum treadmill speed reached by each subject.19  
Statistical Analysis 
Differences between groups were analyzed using the Student’s t-test for independent samples. 
Repeated measures were then performed using 2-way analysis of variance (ANOVA) for season and 
training type, with echocardiography and VO2 max serving as the dependent variables. Post hoc 
Bonferroni analysis identified in what specific season these differences began. The relationship 
between the LVIDd and VO2 max was determined by calculating the Pearson’s product-moment 
correlation coefficient. All calculations were performed using SPSS v.13.0 software (SPSS, Inc., 
Chicago, IL). Significance was set at P < 0.05. 
Results 
Interobserver Coefficient of Variation of Echocardiographic Measurements 
The interobserver coefficient of variation was < 2% for all of the measures considered, and never 
reached statistical significance. 
Echocardiographic Variables of Endurance Runners and Sprinters 
Table 1 demonstrates the mean values of the variables measured for the 2 groups of athletes for the 
whole study. The endurance runners were found to have a larger LVIDs and LVIDd compared with the 
sprinters. Differences were also evident regarding the left atrial anteroposterior diameter at end diastole 
(LADd), both in absolute terms and relative to the body surface area. The endurance runners had a 
significantly larger right ventricular internal diameter and PWTd relative to the body surface area 
compared with the sprinters. Finally, stroke volume, ESV, EDV, and left ventricular mass were found 
to be significantly greater than those of the endurance runners (Table 1). 
View: (Table 1 ) - Echocardiographic Variables in Sprinters Versus Endurance Runners Over the 
5-Year Study Period 
Changes in Cardiac Morphology 
The heart structure in most sprinters remained stable over the 5 seasons (Table 2; Figure 1). However, 
changes were noticeable in some variables for endurance runners from the beginning of the third 
season. The LVIDs remained stable until the beginning of the fourth season, when a significant 
increase was seen compared with the LVIDs from the first season. A significant difference was also 
seen between the first and fifth seasons. 
View: (Table 2 ) - Changes in Echocardiographic Variables Over the 5-Year Study Period 
View: (Figure 1 ) - Changes in LVIDs, LVIDd, and VO2 max over the 5 seasons in both groups of 
athletes (STR and ETR). 
The LVIDd exhibited a similar change, with significant differences recorded from the third to fifth 
seasons (Figure 1). Only 3 sprinters and 6 endurance runners showed values > 60 mm, which are 
dimensions that are normally considered pathological3-5 at some point during the 5-year experimental 
period. 
In the third and fourth seasons, the endurance runners showed a reduction in the LADd in absolute 
terms compared with the first year. When LADd was expressed as relative to body surface area, 
significant differences were seen in the third, fourth, and fifth seasons compared with the first season. 
Finally, the left ventricular ejection fraction decreased significantly in the fourth season (Table 2). 
Relationship Between Left Ventricular Size and Performance 
In all subjects, a nonsignificant correlation (r, 0.23; P = 0.14) was obtained between left ventricular 
size and VO2 max. When the different groups of athletes were analyzed separately, there was no 
significant correlation (sprinters: r = −0.35; P = 0.11; endurance runners: r = −0.02; P = 0.94). 
Discussion 
In our article, we report the results of a large longitudinal study of echocardiographic features in elite 
runners and sprinters. Our cohort was unique in terms of performance abilities, and we also had a 
100% follow-up rate for all athletes in the original cohort. This reflects the dedication of the research 
team as well as the fact that all athletes were required to undergo a compulsory preparticipation 
screening to train and compete.20  
The cardiac morphology of highly trained athletes was assessed with echocardiography at 
physiological levels, with LVIDd never being measured beyond physiological limits.3,5,10,11,21 In the 
long term, the cardiac adaptation to training was found to be similar in endurance runners and sprinters. 
The sprinters showed no significant variations in their echocardiographic dimensions in the study 
period. We also identified no evidence of an association between heart dimensions and VO2 max. 
Figure 1 shows that in endurance runners, the LVIDd changes significantly between the third and fifth 
seasons. In the present study, only 6 runners in the endurance runners group showed LVIDd values of 
> 60 mm (ie, above the pathological threshold).3,5,10,11,21 However, this is similar to findings reported by 
other authors who investigated middle- and long-distance runners.22 An athlete’s athletic career is 
divided into 3 stages: basic training, specialization and achievement of top performance, and 
maintenance of top performance. Our subjects fit into the last category.23 Therefore, their apparent lack 
of cardiac adaptation may result from the absence of any further margin for changes in cardiac 
dimensions.24 The lack of significant change in LVIDd in sprinters over time may result from the 
different type of training they undertake compared with endurance runners. During training, a 
sprinter’s heart is subjected to intense, brief exercise, whereas an endurance runner’s heart provides 
increased ventricular function over long periods. 
The LVIDd is significantly smaller in sprinters (100- and 200-m sprinters) compared with endurance 
runners (n = 29; 50.4 ± 2.15 mm vs n = 58; 54.9 ± 4.36 mm),9 although other authors found no 
differences between such athletes (55.9 ± 4.8 mm vs 53.9 ± 3.8 mm).25 The mechanism responsible for 
the differences in the heart morphology of endurance runners and sprinters might be the increase in 
venous return during the recovery phase.25  
In all subjects studied, both the IVSTd and PWTd decreased more in endurance runners than in 
sprinters (Table 2). This may be because the endurance runners experienced both a reduction in the 
PWTd and an increase in left ventricular volume. In addition, the IVSTd/PWTd ratio remained within 
normal limits in both the sprinters and endurance runners.3,5,10,21 At no point were IVSTd or PWTd 
values recorded at > 11 mm, and the ratio remained at around 1. 
The correlation shows a lack of association between cardiac adaptation (expressed as the change in the 
LVIDd) and the change in performance (expressed as the percentage change in VO2 max) in both 
endurance runners and sprinters. Other authors report a significant correlation (r = 0.67; P < 0.001) 
between changes in LVIDd and performance, expressed as the percentage change in the best speed 
achieved during competition in different seasons.26 However, the same authors report a lack of a 
relationship between the change in VO2 max and performance (r = 0.27; P > 0.05).26 This discrepancy 
and the absence of a relationship in the present study might be related to the fact that VO2 max tends to 
stabilize in highly trained athletes.26 Therefore, VO2 max is also a poor indicator of any adaptations 
made, or improvement in performance in highly trained runners. Further, it is measured at the moment 
of maximum exertion, whereas echocardiographic variables are measured at rest. If VO2 max stabilizes 
in highly trained athletes and performance improves, this improvement must result from other factors, 
such as running economy, increase in anaerobic threshold, or better mechanical efficiency. 
Maximum oxygen consumption is limited by the capacity to capture, pump, transport, and use oxygen; 
therefore, it is not solely a result of the Fick equation, but also depends on Fick’s Principle of Oxygen 
Diffusion.27 In horses, a relationship has been observed between the heart size and VO2 max.28 
However, in homogeneous samples of highly trained athletes, there is a loss of linearity in the 
relationship between VO2 max and cardiac output. This makes VO2 max a poor indicator of 
performance or improvements achieved through training.29 It would be interesting to study other 
submaximal performance variables, such as running economy, and anaerobic, ventilatory, and lactate 
thresholds to determine whether these can offer an explanation for the improvements achieved. 
The athletes who participated in the present investigations were all males. Therefore, our results can 
only be applied to male athletes. Further study would be needed to assess and compare results in an 
equally high ranking group of female endurance and sprint runners. The results of the present study 
demonstrate that heart dimensions of elite runners do not increase above physiological levels, since the 
values are maintained in the normal range along 5 years of intense training. Therefore, the heart 
dimensions evaluated by echocardiography do not reach pathological values after intense training. 
Conclusion 
Our study determined that elite male athletes reach an upper limit of heart adaptation. Over 5 seasons 
of intense training, the changes produced in the echocardiographic variables of male endurance runners 
and sprinters were different, although they did not exceed physiological adaptation limits. Our results 
also demonstrate that in sample of highly trained athletes, VO2 max remained stable during the 5 
seasons, and changes in the heart size are not accompanied by changes in VO2 max. 
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